Viewing Study NCT02758366


Ignite Creation Date: 2025-12-24 @ 4:11 PM
Ignite Modification Date: 2025-12-27 @ 9:09 AM
Study NCT ID: NCT02758366
Status: TERMINATED
Last Update Posted: 2021-02-09
First Post: 2016-04-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Prolonged Exposure to Doxorubicin in Patients With Glioblastoma Multiforme and Diffuse Intrinsic Pontine Glioma
Sponsor: Meyer Children's Hospital IRCCS
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glioblastoma (GBM) View
None DIPG View
None Brainstem Glioma, Pediatric View
None Diffuse Spinal Glioma View
None Bilateral Thalamic Glioma View
None Gliomatosis Cerebri View
None Anaplastic Astrocytoma View
None Midline Diffuse Glioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None glioblastoma multiforme View
None high grade glioma View
None diffuse intrinsic pontine glioma View
None DIPG View
None doxorubicin View
None temozolomide View
None malignant glioma View
None Brainstem Glioma View
None diffuse spinal glioma View
None bilateral thalamic glioma View
None Anaplastic Astrocytoma View
None Gliomatosis Cerebri View
None Midline Diffuse Glioma View